Latest article
Mylan Loses Tribunal Problem to Merck Diabetes Remedy Patent
Merck Sharp & Dohme Corp. fought a patent office challenge filed by Mylan Pharmaceuticals Inc. and other generic drug makers for a patent...
‘Suboptimal metabolic management’ in individuals with arthritis, sort 2 diabetes
medwireNews: Patients with rheumatoid arthritis (RA) or osteoarthritis and comorbid type 2...